4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-000908
CHIEF TECHNICAL OPS OFFICER sold 2,910 shares at an average $28.85 ($83,950)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | 2024-01-08 | Sale 10b5-1 | −1,236 | $28.64 | $35,399 | 63,341 | D: show line 1 in the form |
| Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | 2024-01-08 | Sale 10b5-1 | −53 | $28.64 | $1,518 | 3,834 | I: show line 2 in the form |
| Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | 2024-01-09 | Sale 10b5-1 | −1,521 | $29.01 | $44,132 | 61,820 | D: show line 3 in the form |
| Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | 2024-01-09 | Sale 10b5-1 | −100 | $29.01 | $2,901 | 3,734 | I: show line 4 in the form |
| Open-market sales · 2,910 sh · avg $28.85 · $83,950 | |||||||
Loading xslF345X05/form4-01102024_090133.xml…